Cell Therapy Development And Manufacturing - San Francisco, CA

The growing number of advanced therapeutics gaining approval hold the potential to treat life-threatening diseases and improve patient outcomes, and partnering with a robust, reliable manufacturer is key in enabling the GMP manufacture of cell-based therapies to reach patients efficiently.

Thermo Fisher Scientific’s new facility on the UC San Francisco campus is part of a strategic partnership aiming to solve problems in the cell therapy space. The new facility boasts process development, analytical development, and cGMP manufacturing of autologous and allogeneic therapies across multiple suites. Learn how a partner with the right facility; in-house methods for potency, identity, and sterility; and an experienced team can help deliver your product with time- and cost-efficiency.